Bristol-Myers Squibb BMY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.68B+147% | $1.09B-50.6% | $2.2B+67.2% | $1.31B-46.7% | $2.46B— | ||
| $594M-39.2% | $977M-3.4% | $1.01B0.0% | $1.01B-0.1% | $1.01B-46.2% | ||
| $146M+9.8% | $133M-4.3% | $139M+1.5% | $137M-4.9% | $144M+20.0% | ||
| $1.1B-44.1% | $1.97B-68.7% | $6.31B+61.1% | $3.92B+100% | $1.95B-56.0% | ||
| $347M-6.2% | $370M+15.6% | $320M-11.4% | $361M+38.8% | $260M-31.2% | ||
| $65M-96.2% | $1.71B-8.9% | $1.87B+558% | $285M+265% | $78M+66.0% | ||
| -$131M+91.0% | -$1.46B+14.3% | -$1.7B-260% | -$473M+5.2% | -$499M-155% | ||
| $1.28B+1.7% | $1.26B-0.1% | $1.26B+0.1% | $1.26B+0.3% | $1.26B+3.3% | ||
| $500M-95.0% | $10.07B+4,297% | $229M-64.4% | $643M— | $0— | ||
| -$1.56B+74.1% | -$6.03B-305% | -$1.49B+18.8% | -$1.84B-84.9% | -$993M— | ||
| -$635M+88.5% | -$5.51B-277% | $3.12B+79.4% | $1.74B+229% | $528M— | ||
| $757M-52.8% | $1.6B-73.2% | $5.99B+68.5% | $3.56B+110% | $1.69B-58.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bristol-Myers Squibb generate?
- Bristol-Myers Squibb (BMY) generated $13.3B in operating cash flow over the trailing twelve months.
- What is Bristol-Myers Squibb's free cash flow?
- After $1.4B of capital expenditures, Bristol-Myers Squibb's free cash flow was $11.9B over the trailing twelve months, down 9.0% year over year.
- Where does Bristol-Myers Squibb's cash flow data come from?
- Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
